Genetic Technologies (GENE) Competitors $0.76 0.00 (0.00%) As of 04/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GENE vs. HCWB, IPA, CTXR, ATHA, GOVX, BMRA, NERV, ORGS, FLGC, and CINGShould you be buying Genetic Technologies stock or one of its competitors? The main competitors of Genetic Technologies include HCW Biologics (HCWB), ImmunoPrecise Antibodies (IPA), Citius Pharmaceuticals (CTXR), Athira Pharma (ATHA), GeoVax Labs (GOVX), Biomerica (BMRA), Minerva Neurosciences (NERV), Orgenesis (ORGS), Flora Growth (FLGC), and Cingulate (CING). These companies are all part of the "pharmaceutical products" industry. Genetic Technologies vs. HCW Biologics ImmunoPrecise Antibodies Citius Pharmaceuticals Athira Pharma GeoVax Labs Biomerica Minerva Neurosciences Orgenesis Flora Growth Cingulate Genetic Technologies (NASDAQ:GENE) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation. Is GENE or HCWB more profitable? Genetic Technologies has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. Genetic Technologies' return on equity of 0.00% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Genetic TechnologiesN/A N/A N/A HCW Biologics -1,067.82%-2,516.84%-132.95% Which has more risk & volatility, GENE or HCWB? Genetic Technologies has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Do institutionals and insiders have more ownership in GENE or HCWB? 0.6% of Genetic Technologies shares are owned by institutional investors. Comparatively, 3.0% of HCW Biologics shares are owned by institutional investors. 6.5% of Genetic Technologies shares are owned by company insiders. Comparatively, 49.9% of HCW Biologics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor GENE or HCWB? In the previous week, HCW Biologics had 2 more articles in the media than Genetic Technologies. MarketBeat recorded 9 mentions for HCW Biologics and 7 mentions for Genetic Technologies. Genetic Technologies' average media sentiment score of 0.26 beat HCW Biologics' score of -0.31 indicating that Genetic Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genetic Technologies 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HCW Biologics 0 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation & earnings, GENE or HCWB? Genetic Technologies has higher revenue and earnings than HCW Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenetic Technologies$7.66M0.44-$7.88MN/AN/AHCW Biologics$3.50M3.06-$24.99M-$0.78-0.31 Does the MarketBeat Community prefer GENE or HCWB? Genetic Technologies received 155 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 55.33% of users gave Genetic Technologies an outperform vote. CompanyUnderperformOutperformGenetic TechnologiesOutperform Votes16155.33% Underperform Votes13044.67% HCW BiologicsOutperform Votes6100.00% Underperform VotesNo Votes SummaryGenetic Technologies beats HCW Biologics on 8 of the 13 factors compared between the two stocks. Remove Ads Get Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENE vs. The Competition Export to ExcelMetricGenetic TechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.37M$2.98B$5.54B$7.50BDividend YieldN/A1.53%4.86%4.04%P/E RatioN/A30.4323.2418.08Price / Sales0.44383.25361.2586.83Price / CashN/A168.6838.1634.64Price / Book3.063.646.493.99Net Income-$7.88M-$72.06M$3.21B$247.18M7 Day PerformanceN/A-9.02%-4.91%-4.25%1 Month PerformanceN/A-16.50%-0.08%-6.87%1 Year Performance-73.16%-31.37%6.40%-3.73% Genetic Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeHCWBHCW Biologics1.1338 of 5 stars$0.30-1.2%N/A-85.5%$13.36M$3.50M-0.3040Earnings ReportUpcoming EarningsStock SplitNews CoverageIPAImmunoPrecise Antibodies1.8582 of 5 stars$0.43+1.6%$5.00+1,062.8%-76.6%$13.36M$24.07M-0.5580Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageCTXRCitius Pharmaceuticals2.5026 of 5 stars$1.55+2.0%$54.50+3,416.1%-95.7%$13.32MN/A0.0020Gap DownATHAAthira Pharma1.5022 of 5 stars$0.34+2.4%$13.83+3,968.6%-89.6%$13.27MN/A-0.1240Gap DownGOVXGeoVax Labs3.3842 of 5 stars$1.40+6.9%$14.20+914.3%-43.3%$13.21M$3.09M0.0010Short Interest ↓Gap DownBMRABiomerica0.6471 of 5 stars$0.71+3.6%N/A-35.5%$13.02M$5.58M-2.0960Upcoming EarningsNERVMinerva Neurosciences2.4274 of 5 stars$1.85+2.8%$5.00+170.3%-39.4%$12.94MN/A-4.209Analyst ForecastORGSOrgenesisN/A$2.69-4.0%N/AN/A$12.91M$662,000.000.00150Gap UpFLGCFlora Growth3.3067 of 5 stars$0.66+5.9%$5.00+661.3%-80.9%$12.77M$64.15M0.00280Positive NewsGap UpCINGCingulate3.1447 of 5 stars$3.94-0.5%$16.00+306.1%+284.1%$12.66MN/A0.0020Upcoming EarningsAnalyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies HCWB Alternatives IPA Alternatives CTXR Alternatives ATHA Alternatives GOVX Alternatives BMRA Alternatives NERV Alternatives ORGS Alternatives FLGC Alternatives CING Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GENE) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
